SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending following a strong quarterly earnings report that featured significant revenue growth, though the stock's after-hours gains have faced volatility as investors debate the impact of increased capital expenditure on future profitability. Community sentiment is deeply divided between long-term bulls highlighting a successful turnaround and AI-driven server momentum, and skeptical traders focusing on broader geopolitical risks, tariff concerns, and the potential for share dilution.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors respond to an Orange Book patent listing for Miplyffa that extends exclusivity through 2041, triggering a wave of bullish analyst price target upgrades. The community is actively discussing the stock's tight float and the potential for a strategic buyout, with sentiment boosted by the recent price action reaching five-year highs.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending as investors react to an FDA advisory committee's favorable vote on several peptides, fueling community speculation about a potential short squeeze given the stock's high short interest. While some traders view the regulatory news as a significant growth catalyst for the company's compounding and telehealth platform, others are debating whether the price action reflects a 'buy the rumor, sell the news' scenario or genuine long-term value expansion.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is facing significant market volatility and investor scrutiny as it navigates a challenging telecom landscape, with community discussions intensifying around high debt levels, layoffs, and competitive threats from satellite providers like Starlink. Investors are closely monitoring upcoming earnings and guidance for signs of stabilization, while many long-term shareholders remain focused on the company's dividend yield and recent cost-cutting initiatives as core value drivers.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors anticipate a high-profile media appearance by the CEO to discuss AI in cancer immunotherapy, while the community heavily debates the implications of newly published MD Anderson data regarding standard-of-care survival benchmarks. Many are analyzing this data as a critical catalyst to counter short-seller arguments and validate the potential efficacy of the company's lead pipeline programs ahead of anticipated trial readout milestones.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor is facing significant volatility as investors weigh strong earnings beats and increased share buyback authorizations against analyst downgrades and concerns over sales growth momentum. The community remains deeply divided, with some traders viewing the recent pullbacks as an 'absurd' buying opportunity for a premium brand, while others caution that the stock lacks a clear catalyst to break its current bearish trend.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is facing intense selling pressure as investors react to a challenging earnings report, with the stock sliding to multi-year lows despite a massive share buyback program. The community remains deeply divided, with bears pointing to subscriber losses and debt concerns, while bulls are aggressively accumulating the stock at these levels, betting that the aggressive share retirement and potential strategic pivots will eventually trigger a significant recovery.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart Holdings Inc. is trending as investors react to the company's recent conditional approval to establish Upstart Bank, N.A., while the community remains intensely divided over the stock's future, debating between its potential as a long-term AI-driven lending disruptor and frustration over its volatile price action. Discussions are heavily focused on the stock's high short interest, the upcoming August earnings report, and whether these new banking initiatives will serve as a definitive catalyst for a sustained breakout.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing intense market volatility as investors express deep skepticism over its shifting focus from electric vehicles toward long-term AI, robotics, and robotaxi projects. The community is sharply divided, with many debating whether the stock is a massive buying opportunity or a fundamentally overvalued asset vulnerable to further significant downside.

American Express Co. engages in the provision of card-issuing, merchant-acquiring, and card network businesses. Its products and services include credit cards, business credit cards, corporate programs, gift cards, savings accounts and CDs, and the American Express App. It operates through the following segments: the United States Consumer Services (USCS), Commercial Services (CS), International Card Services (ICS), Global Merchant and Network Services (GMNS), and Corporate and Other. The USCS segment includes proprietary consumer cards and provides services to United States consumers. The CS segment offers corporate and small business cards and provides services to United States businesses. The ICS segment provides consumers, small businesses, and corporate cards outside the United States. The GMNS segment is involved in operating a global payments network that processes and settles card transactions, acquires merchants, and provides multi-channel marketing programs and capabilities, services and data analytics. The Corporate and Other segment covers corporate functions and certain other businesses and operations. It also operates through the following geographical segments: United States, EMEA, APAC, LACC, and Other. The EMEA segment represents Europe, the Middle East, and Africa. The APAC segment refers to Asia Pacific, Australia, and New Zealand. The LACC segment focuses on Latin America, Canada, and the Caribbean. The Other segment includes net costs which are not directly allocated to specific geographic regions. The company was founded by Henry Wells, William G. Fargo, and John Warren Butterfield on March 28, 1850 and is headquartered in New York, NY.

American Express Co.

American Express (AXP) is trending ahead of its earnings release as investors analyze its premium consumer positioning and resilience against potential regulatory interest rate caps. The community is actively debating the stock's valuation, comparing its long-term stability with peers like Visa and Mastercard, while monitoring for signs of margin pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mesoblast Limited (MESO) is a Great Momentum Stock: Should You Buy?

Does Mesoblast Limited (MESO) have what it takes to be a top stock pick for momentum investors? Let's find out.

PayPal, Veradermics, Alibaba And Other Big Stocks Moving Higher On Wednesday

US stocks close higher, Dow Jones up 100 points, PayPal shares rise on $53 billion acquisition proposal, other big gains from Aehr Test, Electrovaya, Robo.ai, Falcon's Beyond, Veradermics, Lucid Group, Kopin, MINISO, Mesoblast, Nexstar, Lionsgate, Karman.read more...

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It PR Newswire NEW YORK, May 22, 2026 Issued on behalf of Conexeu Sciences Inc.Companies mentioned: Conexeu Sciences Inc. (NASDAQ...

Mesoblast (NASDAQ:MESO) Shares Cross Above Fifty Day Moving Average   - Here's Why

Mesoblast (NASDAQ:MESO) Stock Price Crosses Above Fifty Day Moving Average - Here's Why...

Mesoblast (NASDAQ:MESO) Shares Gap Up   - Should You Buy?

Mesoblast (NASDAQ:MESO) Shares Gap Up - What's Next...

Mesoblast Secures Exclusive CAR-MSC Technology License; Stock Up

(RTTNews) - Mesoblast Limited (MESO, MSB.AX) announced the acquisition of an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform. This innovation is designed to enhance the precision and effectiveness of Mesoblast's mesenchymal lineage st...

Insider Buying: Mesoblast (NASDAQ:MESO) Director Buys 1,586,890 Shares of Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 1,586,890 shares of the company's stock in a transaction dated Thursday, April 9th. The stock was acquired at an...

Mesoblast (NASDAQ:MESO) Director Gregory George Purchases 1,586,890 Shares

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George acquired 1,586,890 shares of the firm's stock in a transaction dated Thursday, April 9th. The shares were purchased at an...

Gregory George Acquires 2,324,072 Shares of Mesoblast (NASDAQ:MESO) Stock

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George bought 2,324,072 shares of the business's stock in a transaction on Friday, April 10th. The stock was acquired at an average cost of $1.48 per share, for a total transaction of $3,439,626.56. Following the acquisition, the...

Mesoblast (NASDAQ:MESO) Director Gregory George Purchases 4,000,000 Shares

Mesoblast Limited (NASDAQ:MESO - Get Free Report) Director Gregory George purchased 4,000,000 shares of the business's stock in a transaction on Saturday, April 4th. The stock was purchased at an average cost of $1.42 per share, with a total value of $5,680,000.00. Following the completion of the...

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Mesoblast Ltd - ADR

Mesoblast Gives Positive Update About Potential FDA Application For Heart Failure Therapy: Retail Sees ‘Inflection Point’

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MESOMesoblast limited.

Fundamentals

Latest MESO News